Home LiteratureArticle Details
PMID: 3532944 Published · ppublish English Journal Article

Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Antimicrobial agents and chemotherapy ·Vol. 30 ·No. 2 ·1986-08-00 ·Pages 248-53

Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S

Abstract

We isolated spontaneous mutants from Escherichia coli K-12 with low-level resistance to norfloxacin. These mutants were classified into the following three types on the basis of their properties: (i) NorA appeared to result for mutation in the gyrA locus for the A subunit of DNA gyrase; (ii) NorB showed low-level resistance to quinolones and other antimicrobial agents (e.g., cefoxitin, chloramphenicol, and tetracycline), and the norB gene was considered to map at about 34 min on the E. coli K-12 chromosome; (iii) NorC was less susceptible to norfloxacin and ciprofloxacin but was hypersusceptible to hydrophobic quinolones such as nalidixic acid and rosoxacin, hydrophobic antibiotics, dyes, and detergents. Susceptibility to bacteriophages and the hydrophobicity of the NorC cell surface also differed from that of the parent strain. The norC gene was located near the lac locus at 8 min on the E. coli K-12 chromosome. Both NorB and NorC mutants had a lower rate of norfloxacin uptake, and it was found that the NorB mutant was altered in OmpF porin and that the NorC mutant was altered in both OmpF porin and apparently in the lipopolysaccharide structure of the outer membrane.

MeSH Terms
Bacterial Outer Membrane Proteins/analysis Chromosome Mapping Chromosomes, Bacterial Coliphages/physiology Drug Resistance, Microbial Escherichia coli/drug effects,genetics,isolation & purification Genes, Bacterial Microbial Sensitivity Tests Mutation Norfloxacin/metabolism,pharmacology
Chemicals
Bacterial Outer Membrane Proteins Norfloxacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hirai K
Aoyama H
Suzue S
Irikura T
Iyobe S
Mitsuhashi S
References (31)
31 references, click to expand
  1. Isolation of outer membrane proteins of Escherchia coli and their characterization on polyacrylamide gel.
    Biochim Biophys Acta. 1975 Dec 1;413(2):163-76 PMID: 1103976
  2. Transduction of linked genetic characters of the host by bacteriophage P1.
    Virology. 1955 Jul;1(2):190-206 PMID: 13267987
  3. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Antimicrob Agents Chemother. 1978 Aug;14(2):240-5 PMID: 358918
  4. Chromosomal location and expression of the structural gene for major outer membrane protein Ia of Escherichia coli K-12 and of the homologous gene of Salmonella typhimurium.
    J Bacteriol. 1979 Aug;139(2):468-77 PMID: 378974
  5. Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane.
    J Bacteriol. 1979 Sep;139(3):899-910 PMID: 383699
  6. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
    Antimicrob Agents Chemother. 1980 Feb;17(2):103-8 PMID: 6446258
  7. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
    J Bacteriol. 1969 Jul;99(1):238-41 PMID: 4895844
  8. Role of lipopolysaccharides in antibiotic resistance and bacteriophage adsorption of Escherichia coli K-12.
    J Bacteriol. 1971 Mar;105(3):968-75 PMID: 4926688
  9. Studies on the mechanism of action of nalidixic acid.
    Antimicrob Agents Chemother. 1973 Oct;4(4):479-86 PMID: 4208771
  10. The mechanism of action of fosfomycin (phosphonomycin).
    Ann N Y Acad Sci. 1974 May 10;235(0):364-86 PMID: 4605290
  11. Identification of OmpR: a positive regulatory protein controlling expression of the major outer membrane matrix porin proteins of Escherichia coli K-12.
    J Bacteriol. 1981 Jul;147(1):255-8 PMID: 6263866
  12. New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
    J Bacteriol. 1981 Nov;148(2):450-8 PMID: 6271730
  13. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin.
    Antimicrob Agents Chemother. 1981 Oct;20(4):549-52 PMID: 7044293
  14. Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae.
    Antimicrob Agents Chemother. 1982 Oct;22(4):585-92 PMID: 6758687
  15. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams.
    Antimicrob Agents Chemother. 1982 Dec;22(6):942-8 PMID: 6760806
  16. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
    Antimicrob Agents Chemother. 1983 Jan;23(1):188-9 PMID: 6219620
  17. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Antimicrob Agents Chemother. 1983 Apr;23(4):559-64 PMID: 6222695
  18. Selection and characterization of beta-lactam-resistant Escherichia coli K-12 mutants.
    Antimicrob Agents Chemother. 1983 Apr;23(4):622-5 PMID: 6344786
  19. Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics.
    J Bacteriol. 1983 Aug;155(2):541-8 PMID: 6307967
  20. Linkage map of Escherichia coli K-12, edition 7.
    Microbiol Rev. 1983 Jun;47(2):180-230 PMID: 6348505
  21. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Antimicrob Agents Chemother. 1984 Jun;25(6):775-7 PMID: 6234858
  22. Mutational resistance to 4-quinolone antibacterial agents.
    Eur J Clin Microbiol. 1984 Aug;3(4):347-50 PMID: 6237904
  23. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
    Antimicrob Agents Chemother. 1984 Dec;26(6):797-801 PMID: 6098219
  24. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.
    J Infect Dis. 1985 Mar;151(3):501-7 PMID: 2982966
  25. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    J Gen Microbiol. 1985 Sep;131(9):2285-92 PMID: 3906038
  26. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  27. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Antimicrob Agents Chemother. 1986 Apr;29(4):639-44 PMID: 3010850
  28. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
    Antimicrob Agents Chemother. 1986 Mar;29(3):535-8 PMID: 3521490
  29. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
    Antimicrob Agents Chemother. 1986 Jun;29(6):1059-66 PMID: 2942103
  30. Mutants of Escherichia coli requiring methionine or vitamin B12.
    J Bacteriol. 1950 Jul;60(1):17-28 PMID: 15436457
  31. Conjugation deficient E. coli K12 F- mutants with heptose-less lipopolysaccharide.
    Mol Gen Genet. 1976 July 5;146(1):43-50 PMID: 785207
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1986-08-00
Pages
248-53
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC180528
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]